Clinical trial characteristics for tumors:
Complex design of protocol, various data acquisition types, multiple methods and large number of times for trial evaluation; large period span, uncertain follow-up period, and long follow-up time; involving data acquisition for Biomarker multiple samples and pathology, imaging, etc.; high requirements for data logic quality, complicated centralized evaluation procedure.

GCP advantages:
We have full-time, project management experienced project manager team and good and extensive partnership with hospitals. Using company's clear SOP procedure and clinical trial management system (CTMS), adequate training, and reasonably designed program support and follow-up management tools (CTMS) and electronic data system, we can audit data in multi-level regularly, provide rapid support to the site for monitoring of clinical study data in a timely manner, so provide optimal management for the development of clinical trials of tumors.

Our clinical trial experience includes, but is not limited to, the following cancer indications:
Non-small cell lung cancer, breast cancer, liver cancer, digestive tract tumor, B/T cell lymphoma, chronic myeloid leukemia, acute lymphocytic leukemia, head and neck squamous cell carcinoma, etc.